Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by edubon Feb 25, 2011 10:44am
289 Views
Post# 18193589

RE: @funfinder

RE: @funfinderHi Viking.. havent posted on RVX board before, but have been holding a small amount of stock since that last spike...got rid of most during the downward trend from the 4s and 6s... Just curious what is going on these days?  I read through some of the posts herein, see that you and others have mentioned march 15 as a due date for something?  Could you or someone please fill me in on the relevant topics?  Last real involvement I had was when the NR's were coming out about the Phase 2 assert results and DM pretty much tanked the thing, I THINK it was DM..it was a podcast I watched, and many were soured by the way it was presented and handled (myself included...) anyways, yes I see the rumblings of the money issues... this has been on my mind and money is the name of the game in small pharma... are there potential investors coming?  What about the proximity of the Assert/assure studies to others by big players who may be interested in a takeout?  I dont think a split would be good at this point, they are just not looking too good..are there potential funders, or potential good news that will help spike the situation coming around soon?  Any info is hugely appreciated, and thanks in advance!  GLTA
Bullboard Posts